T-1301 / National Health Research Institutes, Taivex Therapeutics Corporation  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
T-1301 / Taivex Therapeutics Corporation, National Health Research Institutes
NCT05156203: Safety and Tolerability Study for T-1301 Capsules to Treat Advanced Solid Tumors

Recruiting
1
30
RoW
T-1301 Capsules
Taivex Therapeutics Corporation
Advanced Solid Tumor, Lymphoma
01/25
12/25

Download Options